Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First phase I results for MSB-0010718C in advanced solid malignancies

June 11, 2014

Novel HIV-infected, humanized mouse model developed with antiviral PK/PD capabilities

June 11, 2014

COMBI-d: first phase III trial of dabrafenib + trametinib in metastatic melanoma

June 10, 2014

First-in-human results for anti-IGF-I/II antibody BI-836845

June 10, 2014

PENELOPE data: pertuzumab + topotecan + paclitaxel in ovarian cancer

June 10, 2014

OMP-59R5 plus etoposide is well tolerated in SCLC patients

June 10, 2014

PD-404182 evaluated as an anti-HIV and anti-HSV microbicidal candidate

June 10, 2014

microRNAs mir-21 and mir-221 overexpressed in placentas from patients with pre-eclampsia

June 6, 2014

GlaxoSmithKline presents first-in-human results for GSK-2636771

June 6, 2014

New phase II trial evaluation of PLX-3397 as a single agent in patients with recurrent glioblastoma

June 6, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...